Monoclonal antibodies specific for the capsid protein of chikungunya virus suitable for multiple applications

Chikungunya outbreak in the Caribbean region, December 2013 to March 2014, and the significance for Europe

(2014) W Van Bortel et al.   Eurosurveillance

Neutralizing monoclonal antibodies to the E2 protein of chikungunya virus protects against disease in a mouse model

(2013) Lucas Y.H. Goh et al.   CLINICAL IMMUNOLOGY

Interferon Response Factors 3 and 7 Protect against Chikungunya Virus Hemorrhagic Fever and Shock

(2012) Penny A. Rudd et al.   JOURNAL OF VIROLOGY

Arthritogenic alphaviruses—an overview

(2012) Andreas Suhrbier et al.   Nature Reviews Rheumatology

Emergence and clinical insights into the pathology of Chikungunya virus infection

(2010) Marie Christine Jaffar-Bandjee et al.   Expert Review of Anti-Infective Therapy

Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages

(2010) Karine Labadie et al.   JOURNAL OF CLINICAL INVESTIGATION

Persistent Chronic Inflammation and Infection by Chikungunya Arthritogenic Alphavirus in Spite of a Robust Host Immune Response

(2010) J. J. Hoarau et al.   JOURNAL OF IMMUNOLOGY

Chikungunya Virus Arthritis in Adult Wild-Type Mice

(2010) J. Gardner et al.   JOURNAL OF VIROLOGY

Chikungunya Fever: An Epidemiological Review of a Re‐Emerging Infectious Disease

(2009) J. Erin Staples et al.   CLINICAL INFECTIOUS DISEASES

Systemic involvements and fatalities during Chikungunya epidemic in India, 2006

(2009) Babasaheb V. Tandale et al.   JOURNAL OF CLINICAL VIROLOGY

Atypical Chikungunya virus infections: clinical manifestations, mortality and risk factors for severe disease during the 2005–2006 outbreak on Réunion

(2008) A. ECONOMOPOULOU et al.   EPIDEMIOLOGY AND INFECTION